Bruno P. Imbimbo 个人学术档案

引用次数

	总计	2019 年至今
引用	14722	6285
h 指数	68	37
i10 指数	190	109

1300

650

325

975

199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202451 67 116 62 102 124 187 292 206 182 175 137 136 124 99 136 124 139 156 310 515 575 652 691 659 664 708 743 841 1102 1193 1231 1278 617

开放获取的出版物数量

查看全部

25 篇文章

9 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Francesco PanzaNeurodegenerative Disease Unit, Department of Basic Medicine, Neuroscience, and Sense Organs在 uniba.it 的电子邮件经过验证
vincenzo solfrizziuniversity of bari在 uniba.it 的电子邮件经过验证
Davide SeripaBiologo Dirigente di Ricerca, U.O.C. Geriatria, I.R.C.C.S. "Casa Sollievo della Sofferenza".在 operapadrepio.it 的电子邮件经过验证
Giancarlo LogroscinoFull Professor of Neurology, University of Bari. Director of the Center for Neurodegenerative在 uniba.it 的电子邮件经过验证
Antonio GrecoAssociate professor of otorhinolaryngology, Sapienza University of Rome在 uniroma1.it 的电子邮件经过验证
Antonio Danieleassistant professor, Catholic University, Rome, Italy在 unicatt.it 的电子邮件经过验证
Gabrio BassottiClinica di Gastroenterologia ed Epatologia, Dipartimento di Medicina, Università di Perugia在 unipg.it 的电子邮件经过验证
Nunzio PomaraProfessor of Psychiatry and Pathology NYU Langone Medical Center在 nki.rfmh.org 的电子邮件经过验证
Marina PizziFull Professor of Pharmacology University of Brescia在 unibs.it 的电子邮件经过验证
Rodolfo Sardone, MPHHead of Urban Health Center, Local Healthcare Authority of Taranto在 asl.taranto.it 的电子邮件经过验证
Emanuele SCAFATOEpidemiologo, Gastroenterologo, Direttore Osserv. Naz. Alcol e Centro OMS ricerca alcol在 iss.it 的电子邮件经过验证
Daniele SancarloResearcher. IRCCS Casa Sollievo delle Sofferenza. San Giovanni Rotondo. Italy.在 operapadrepio.it 的电子邮件经过验证
Gianluigi GiannelliDirettore Scientifico IRCCS "Saverio de Bellis"在 irccsdebellis.it 的电子邮件经过验证
marzia baldereschimedico ricercatore Consiglio Nazionale delle Ricerche在 in.cnr.it 的电子邮件经过验证
Domenico InzitariDept. Neurofarba, Florence University, Italy在 unifi.it 的电子邮件经过验证
Lucia GalluzzoSenior Researcher, Istituto Superiore di Sanità在 iss.it 的电子邮件经过验证
Antonio Di CarloInstitute of Neurosciences, Italian National Research Council在 in.cnr.it 的电子邮件经过验证
Vittorio DibelloDepartment of Orofacial Pain and Dysfunction, Academic Centre of Dentistry Amsterdam (ACTA)在 acta.nl 的电子邮件经过验证
Vito GUERRAIRCCS De Bellis - Castellana Grotte - Italy在 irccsdebellis.it 的电子邮件经过验证
Andrea GiustinaUniversità Vita Salute San Raffaele, Milano在 hsr.it 的电子邮件经过验证

关注

Bruno P. Imbimbo

Chiesi Farmaceutici

在 chiesi.com 的电子邮件经过验证

Alzheimer


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
A critical appraisal of amyloid-β-targeting therapies for Alzheimer disease F Panza, M Lozupone, G Logroscino, BP Imbimbo Nature Reviews Neurology 15 (2), 73-88, 2019	866	2019
Late-life depression, mild cognitive impairment, and dementia: possible continuum? F Panza, V Frisardi, C Capurso, A D'Introno, AM Colacicco, BP Imbimbo, ... The American Journal of Geriatric Psychiatry 18 (2), 98-116, 2010	793	2010
The β-secretase BACE1 in Alzheimer’s disease H Hampel, R Vassar, B De Strooper, J Hardy, M Willem, N Singh, J Zhou, ... Biological psychiatry 89 (8), 745-756, 2021	474	2021
Diet and Alzheimer’s disease risk factors or prevention: the current evidence V Solfrizzi, F Panza, V Frisardi, D Seripa, G Logroscino, BP Imbimbo, ... Expert review of neurotherapeutics 11 (5), 677-708, 2011	409	2011
Relationships of dietary patterns, foods, and micro-and macronutrients with Alzheimer’s disease and late-life cognitive disorders: a systematic review V Solfrizzi, C Custodero, M Lozupone, BP Imbimbo, V Valiani, P Agosti, ... Journal of Alzheimer's Disease 59 (3), 815-849, 2017	350	2017
Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment? BP Imbimbo, V Solfrizzi, F Panza Frontiers in aging neuroscience 2, 1517, 2010	325	2010
Colonic mass movements in idiopathic chronic constipation. G Bassotti, M Gaburri, BP Imbimbo, L Rossi, F Farroni, MA Pelli, A Morelli Gut 29 (9), 1173-1179, 1988	278	1988
γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes B P Imbimbo, G AM Giardina Current topics in medicinal chemistry 11 (12), 1555-1570, 2011	251	2011
A path toward precision medicine for neuroinflammatory mechanisms in Alzheimer's disease H Hampel, F Caraci, AC Cuello, G Caruso, R Nisticò, M Corbo, F Baldacci, ... Frontiers in immunology 11, 456, 2020	244	2020
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms V Frisardi, F Panza, D Seripa, BP Imbimbo, G Vendemiale, A Pilotto, ... Journal of Alzheimer's Disease 22 (3), 715-740, 2010	226	2010
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man E Ghigo, E Arvat, L Gianotti, BP Imbimbo, V Lenaerts, R Deghenghi, ... The Journal of Clinical Endocrinology & Metabolism 78 (3), 693-698, 1994	209	1994
Tau‐Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer’s Disease F Panza, V Solfrizzi, D Seripa, BP Imbimbo, M Lozupone, A Santamato, ... BioMed research international 2016 (1), 3245935, 2016	207	2016
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms F Panza, V Frisardi, C Capurso, BP Imbimbo, G Vendemiale, A Santamato, ... Journal of Alzheimer's disease 21 (3), 691-724, 2010	199	2010
Therapeutic potential of γ-secretase inhibitors and modulators BP Imbimbo Current topics in medicinal chemistry 8 (1), 54-61, 2008	189	2008
Amyloid‐β immunotherapy for alzheimer disease: Is it now a long shot? F Panza, M Lozupone, D Seripa, BP Imbimbo Annals of neurology 85 (3), 303-315, 2019	175	2019
Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease BP Imbimbo, S Ottonello, V Frisardi, V Solfrizzi, A Greco, D Seripa, ... Expert review of clinical immunology 8 (2), 135-149, 2012	174	2012
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? F Panza, V Frisardi, D Seripa, G Logroscino, A Santamato, BP Imbimbo, ... International journal of geriatric psychiatry 27 (12), 1218-1238, 2012	172	2012
Synthesis and Biological Activity of Flurbiprofen Analogues as Selective Inhibitors of β-Amyloid₁_-₄₂ Secretion I Peretto, S Radaelli, C Parini, M Zandi, LF Raveglia, G Dondio, ... Journal of Medicinal Chemistry 48 (18), 5705-5720, 2005	171	2005
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer’s disease BP Imbimbo CNS drugs 15, 375-390, 2001	167	2001
Frailty syndrome and the risk of vascular dementia: the Italian Longitudinal Study on Aging V Solfrizzi, E Scafato, V Frisardi, D Seripa, G Logroscino, S Maggi, ... Alzheimer's & Dementia 9 (2), 113-122, 2013	158	2013

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用